Suprised ANNOUNCMENT ! Urduximab (Dlbchinoff) Approved indication: Rx only, double chin remover cream and suppository Market potential BLOCKBUSTER: $14,000,000,000.00 first year sale Launch Date April 1, 2018
“So stupid” ?? Well your the tard checking this site and reading my posts plus repping Hear that all adds up to loser. Now I hear you handler is working with you next week! Better line up that lunch and big sales call!!
You must be, for now “employed” here, tell me what’s it like, failing company, me two product, selling in a price non provider influenced bio similar arena? Come on silly what’s it like, for now?
such a dipshit. UCB is fine, additional call points coming soon. Launching new drug next year possibly. And biosimilar have no impact to date you idiot. Make sure you know what you’re talking about before making stupid comments. You big dummy.
Oh that’s why you have lost a ton of “talent” to REGN to other real large module companies and oh your bone drug is dead but your detail men are not privy to the insider news. Shtick with booking lunches and impressing your district manager with milk runs, folks likes yous deserve to be disembowled.
Hear is what it takes to be a rock star UCB drug rep and a buy n bill super star: a contemptible or inept person